Evidence map›Paper›PMID 35850699›Full record

ArticleBMC infectious diseases2022

The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone.

Samuel C Ficenec, Donald S Grant, Ibrahim Sumah, Foday Alhasan, Mohamed S Yillah, Jenneh Brima, Edwin Konuwa, Michael A Gbakie, Fatima K Kamara, Nell G Bond and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Metabolic Basis of Post-Infectious Sequelae After Ebola Virus Disease.medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Samuel C FicenecDepartment of Internal Medicine, Tulane University School of Medicine, New Orleans, LA, USA. sficenec@tulane.edu.
Donald S GrantKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Ibrahim SumahKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Foday AlhasanKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Mohamed S YillahKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Jenneh BrimaKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Edwin KonuwaKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Michael A GbakieKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Fatima K KamaraKenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
Nell G BondDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, USA.
Emily J EngelDepartment of Pediatrics, Section of Infectious Diseases, Tulane University School of Medicine, New Orleans, LA, USA.
Jeffrey G ShafferDepartment of Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
William A FischerDepartment of Internal Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
David A WohlDepartment of Internal Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Susan D EmmettDepartment of Epidemiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
John S SchieffelinDepartment of Pediatrics, Section of Infectious Diseases, Tulane University School of Medicine, New Orleans, LA, USA.
Tulane University · USUniversity of North Carolina at Chapel Hill · USUniversity of Arkansas for Medical Sciences · USUniversity of Sierra Leone · SL

Funding

UJMT – ORWH – Gazzetta, Issa-BoubeD43TW009340 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI William Checkley, Benjamin H. Chi · 2017 to 2026
$14.8M
Tulane Building Interdisciplinary Research Careers in Women's Health (BIRCWH)K12HD043451 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI KROUSEL-WOOD, MARIE · 2002 to 2023
$9.9M
Building Interdisciplinary Research Careers in Women's HealthK12AR084224 · NIAMS · TULANE UNIVERSITY OF LOUISIANA · PI Marie Krousel-Wood · 2024 to 2026
$1.6M
Tulane StARR ProgramR38HL155774 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI JAY K KOLLS, Marie Krousel-Wood · 2021 to 2026
$1.5M
FIC NIH HHS D43 TW009340FIC NIH HHS D43TW009340NHLBI NIH HHS R38 HL155774NIAMS NIH HHS K12 AR084224NICHD NIH HHS K12 HD043451NIH HHS 5K12HD043451
6 · The paper itself

Abstract

backgroundGlobally, hearing loss is the second leading cause of disability, affecting approximately 18.7% of the world's population. However, the burden of hearing loss is unequally distributed, with the majority of affected individuals located in Asia or Sub-Saharan Africa. Following the 2014 West African Ebola Outbreak, disease survivors began to describe hearing loss as part of the constellation of symptoms known as Post-Ebola Syndrome. The goal of this study was to more fully characterize hearing loss among Ebola Virus Disease (EVD) survivors. METHODOLOGY AND PRINCIPAL

findingsEVD survivors and their household contacts were recruited (n = 1,12) from Eastern Sierra Leone. Each individual completed a symptom questionnaire, physical exam, and a two-step audiometry process measuring both air and bone conduction thresholds. In comparison to contacts, EVD survivors were more likely to have complaints or abnormal findings affecting every organ system. A significantly greater percentage of EVD survivors were found to have hearing loss in comparison to contacts (23% vs. 9%, p < 0.001). Additionally, survivors were more likely to have bilateral hearing loss of a mixed etiology. Logistic regression revealed that the presence of any symptoms of middle or inner ear (p < 0.001), eye (p = 0.005), psychiatric (p = 0.019), and nervous system (p = 0.037) increased the odds of developing hearing loss. CONCLUSIONS AND SIGNIFICANCE: This study is the first to use an objective and standardized measurement to report hearing loss among EVD survivors in a clinically meaningful manner. In this study it was found that greater than 1/5th of EVD survivors develop hearing loss. The association between hearing impairment and symptoms affecting the eye and nervous system may indicate a similar mechanism of pathogenesis, which should be investigated further. Due to the quality of life and socioeconomic detriments associated with untreated hearing loss, a greater emphasis must be placed on understanding and mitigating hearing loss following survival to aid in economic recovery following infectious disease epidemics.

Indexed as

Hearing LossHemorrhagic Fever, EbolaSurvivorsDisease OutbreaksHumansPrevalenceSierra Leone

Identifiers

PMID35850699
PMCPMC9290210
OpenAlexW4285727449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.